Review Article
Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine
Table 6
Tissue engineering therapies using MSCs.
| Disease | Study organism | Cell | Scaffold | Outcome | Reference |
| Osteochondral defect | Rabbit | Autologous MSCs | Injectable synthetic ECM | Cartilage filled the full-thickness defect | [242] | Spinal cord injury | Rat | Autologous MSCs | Hydrogels | Enhanced ingrowth of axons in the lesion and improvement in function | [243] | Critical size bone defect | Mouse | OSX-modified murine MSCs | Collagen sponge | Enhanced bone formation | [244] | Tendon defect | Rat | C3H10T1/2 cells stably transfected with BMP-2 and active Smad8 variant | Collagen sponge | Tendon regeneration | [245] | Articular cartilage defect | Rabbit | Autologous MSCs modified with TGF-1 | Chitosan scaffold | Enhanced repair; defect filled with hyaline cartilage | [246] |
|
|